Skip to main content







MT Group | Expert Collection and Transport of Clinical Specimens

Advancing Medical Research Through Expert Collection and Transport of Clinical Specimens

Welcome to MT Group, where we are dedicated to empowering researchers and medical professionals with unparalleled access to custom biospecimen collections. Our services focus on the meticulous collection and transport of clinical specimens, ensuring each sample meets the highest standards of quality and reliability. What sets us apart is our commitment to providing comprehensive clinical annotations, delivering detailed and accurate data alongside every specimen. This combination equips researchers with the critical tools needed to drive innovation, uncover new insights, and accelerate scientific discovery in fields ranging from oncology to infectious disease research.

In today’s rapidly advancing field of medical research, the availability of high-quality clinical specimens is essential. These biological materials—whether blood, tissue, or other biofluids—form the backbone of studies that lead to groundbreaking discoveries, such as novel therapies, diagnostic tools, and improved patient outcomes. However, obtaining specimens that align with specific research criteria, paired with robust clinical data, poses a significant challenge for many investigators. At MT Group, we address this need head-on by offering tailored solutions designed to meet the unique demands of your projects, ensuring that every specimen we provide is a stepping stone toward meaningful results.

Our expertise in the collection and transport of clinical specimens is rooted in decades of experience and a deep understanding of the scientific process. We recognize that the integrity of a specimen is only as valuable as the care taken during its procurement and delivery. That’s why we employ rigorous protocols and cutting-edge technology to preserve sample quality from the point of collection to its arrival at your facility. Coupled with our comprehensive clinical annotations—which include patient demographics, medical histories, and treatment details—our services offer a level of precision and reliability that researchers can trust. Whether you’re conducting exploratory studies or supporting large-scale clinical trials, MT Group is your partner in pushing the boundaries of medical science.

We invite you to explore how our offerings can elevate your research. With a steadfast commitment to quality, ethical standards, and client satisfaction, MT Group has earned its reputation as a leader in biospecimen procurement. Learn more about our capabilities by visiting our services page, where we detail the full scope of our expertise and how we can support your next breakthrough.

Custom Biospecimen Collections Tailored to Your Research Goals

At MT Group, we understand that no two research projects are alike. The specific needs of your study—whether it’s investigating a rare disease, validating a biomarker, or developing a new treatment—demand specimens that align precisely with your objectives. This is where our custom biospecimen collections shine. We work closely with you to define the exact parameters for the samples you require, ensuring that every aspect of the collection and transport of clinical specimens is customized to your specifications. From blood and tissue to specialized biofluids, we deliver the materials you need with an unwavering focus on quality and consistency.

Our process begins with a thorough consultation to understand your research goals. Perhaps your study requires tissue samples from patients with a specific cancer subtype, or maybe you need longitudinal blood samples from a particular demographic group. Whatever the case, our team has the expertise to source and collect these specimens with precision. We handle a wide range of biological materials, including whole blood, plasma, serum, fresh or frozen tissues, urine, saliva, and even cerebrospinal fluid. Each specimen is gathered under strict ethical guidelines, with full compliance to institutional review board approvals and patient consent requirements, ensuring that your research adheres to the highest standards of integrity.

The collection and transport of clinical specimens is a delicate process that requires meticulous attention to detail. At MT Group, we employ state-of-the-art preservation techniques, such as cryopreservation and temperature-controlled storage, to maintain the viability of each sample. Our transport systems are equally advanced, utilizing validated shipping methods and real-time temperature monitoring to prevent degradation during transit. This ensures that when your specimens arrive, they are in optimal condition for analysis, whether you’re performing genomic sequencing, proteomic profiling, or histopathological examination.

What truly distinguishes our service is our ability to handle complex, custom requests. For instance, if your research necessitates specimens from donors with specific genetic markers or treatment histories, our extensive network of collection sites and partnerships with medical institutions enables us to meet those needs. We source samples from diverse populations across the globe, enhancing the applicability and relevance of your findings. By choosing MT Group, you gain access to a level of customization and reliability that sets the foundation for successful research outcomes.

Comprehensive Clinical Annotations: Enhancing the Value of Every Specimen

A biospecimen’s utility extends far beyond its physical properties—it’s the accompanying clinical data that unlocks its full potential. At MT Group, we go beyond simply providing high-quality specimens; we deliver comprehensive clinical annotations that offer critical context for your research. Each sample comes with a detailed dataset, meticulously compiled to include patient demographics, medical histories, diagnostic information, treatment records, and, where applicable, longitudinal follow-up data. This depth of information empowers researchers to perform more precise analyses, leading to discoveries that might otherwise remain out of reach.

Our clinical annotations are curated by a team of medical professionals with extensive expertise in the field. Led by our Founder and Chief Medical Officer, Dr. Tom Moss, we ensure that every piece of data is accurate, thorough, and compliant with regulatory standards. For example, a tissue sample from a cancer patient might include details on the tumor’s stage and grade, the patient’s chemotherapy regimen, and their response to treatment over time. Similarly, a blood sample from an infectious disease study could be annotated with the patient’s viral load, symptoms, and vaccination status. This level of detail transforms raw specimens into powerful research tools.

The importance of comprehensive clinical annotations cannot be overstated. In fields like personalized medicine, where understanding the interplay between genetics, lifestyle, and treatment outcomes is key, this data provides the foundation for identifying new biomarkers or tailoring therapies to individual patients. Our standardized data collection methods and adherence to privacy regulations, such as HIPAA and GDPR, ensure that the information is both reliable and secure. By partnering with MT Group, you gain access to a wealth of clinical insights that enhance the scientific rigor and impact of your work.

We take pride in our ability to deliver annotations that meet the specific needs of your study. Whether you require basic demographic information or in-depth pathological reports, our team collaborates with you to provide the data points most relevant to your research questions. This tailored approach, combined with our commitment to quality, positions MT Group as a trusted ally for researchers seeking to advance medical knowledge and improve human health.

Why MT Group is Your Ideal Partner in Biospecimen Procurement

Selecting a provider for the collection and transport of clinical specimens is a decision that can shape the success of your research. At MT Group, we offer a suite of advantages that make us the preferred choice for leading research institutions, pharmaceutical companies, and academic investigators. Our leadership team, including Marc Siegel, Founder and President, and John Kibler, VP of Business Development, brings a wealth of experience in both the scientific and operational aspects of biospecimen procurement, ensuring that our services are both cutting-edge and client-focused.

One of our core strengths is our unwavering commitment to quality assurance. Every step of our process—from specimen collection to transport to data annotation—is governed by rigorous quality control measures. We use advanced technology, such as automated storage systems and real-time tracking, to maintain specimen integrity. Our facilities are designed to meet the demands of modern research, with robust infrastructure that supports the preservation and handling of even the most sensitive biological materials. This dedication to quality ensures that the specimens you receive are ready for immediate use in your experiments or trials.

Another reason to choose MT Group is our ability to offer truly custom solutions. We don’t believe in one-size-fits-all approaches; instead, we take the time to understand your research goals and tailor our services accordingly. Whether you need a small batch of highly specific samples or a large volume of specimens for a multi-center study, we have the flexibility and scalability to deliver. Our global network of collection sites allows us to source specimens from diverse populations, providing you with the breadth and depth needed to address complex research questions.

Our client-centric philosophy is reflected in the glowing feedback we’ve received from those we’ve served. Researchers consistently praise our reliability, responsiveness, and the value we add to their projects. You can read more about their experiences on our testimonials page, where satisfied clients share how MT Group has helped them achieve their scientific objectives. From initial consultation to final delivery, our dedicated account managers are with you every step of the way, ensuring a seamless and supportive experience.

Finally, our adherence to ethical standards sets us apart. We prioritize patient consent, data privacy, and regulatory compliance in all our operations, giving you confidence that your research is built on an ethical foundation. With MT Group, you’re not just getting a service provider—you’re gaining a partner committed to your success and the advancement of medical science.

The Impact of Quality Biospecimens on Research Outcomes

The quality of the biospecimens you use directly influences the reliability and reproducibility of your research findings. A specimen that has been mishandled or lacks sufficient clinical context can lead to flawed conclusions, squandering time, funding, and effort. At MT Group, we recognize this critical link and are dedicated to providing specimens that meet the highest standards, enabling you to produce results that stand up to scrutiny and contribute to scientific progress.

Our custom biospecimen collections have played a pivotal role in a wide range of research areas. In cancer research, for example, we’ve supplied tumor tissues accompanied by detailed pathology reports, helping investigators develop targeted therapies that address specific molecular profiles. For infectious disease studies, our biofluids from affected patients have supported the creation of vaccines and the tracking of epidemiological trends. In genetic research, our specimens with comprehensive genetic annotations have fueled discoveries in hereditary diseases and personalized medicine, while our longitudinal data has aided in the identification of novel biomarkers for early diagnosis.

By delivering specimens that are both high-quality and richly annotated, MT Group empowers researchers to explore new frontiers in healthcare. Our work has contributed to advancements that improve patient care, from refining diagnostic techniques to accelerating drug development. When you partner with us, you’re tapping into a resource that not only meets your immediate needs but also helps drive the broader mission of improving human health through rigorous, impactful science.

Our Commitment to Quality at Every Step

Quality is the cornerstone of MT Group’s operations. We’ve built a comprehensive quality assurance program that oversees every facet of the collection and transport of clinical specimens, ensuring that each sample and its accompanying data meet the exacting standards required for cutting-edge research. Our processes are designed with precision and accountability in mind, from the moment a specimen is collected to its delivery at your doorstep.

Our collection protocols are standardized and rigorously enforced, drawing on best practices to ensure consistency across all samples. Whether we’re handling fresh tissues or fragile biofluids, we employ advanced preservation methods to maintain their integrity. During transport, our logistics team uses validated shipping solutions equipped with temperature monitoring systems, guaranteeing that specimens remain stable regardless of distance or environmental conditions. This attention to detail minimizes the risk of degradation and ensures that your samples arrive in pristine condition.

The clinical data we provide undergoes a similarly thorough process. Our medical team, including experienced data specialists, verifies and validates every annotation, conducting multiple reviews to eliminate errors. We comply with all relevant regulations, including those set by the FDA and EMA, making our specimens and data suitable for use in regulated research environments like clinical trials. Moreover, we’re committed to continuous improvement, regularly updating our methods based on client feedback and advancements in the field to deliver an ever-higher level of service.

This relentless focus on quality gives you confidence in the materials you receive from MT Group. Whether you’re analyzing specimens in a lab or presenting findings to stakeholders, you can trust that our contributions are accurate, reliable, and scientifically sound.

Meet the Experts Driving Our Mission

Behind every specimen and annotation at MT Group is a team of dedicated professionals with deep expertise in medical research and biospecimen procurement. Our leadership combines clinical knowledge with operational excellence, ensuring that our services meet the needs of the scientific community. To learn more about the individuals steering our mission, visit our Who We Are page, where you can explore the backgrounds and contributions of our key team members.

Stay Connected with MT Group

We’re passionate about keeping our clients and the broader research community informed about the latest developments in biospecimen research. Our blog features insightful articles on industry trends, research applications, and best practices. You can also check out our upcoming events to connect with us in person or explore our current promotions to take advantage of special offers on our services.

If you have questions about our processes or offerings, our FAQ page provides detailed answers to common inquiries, offering a quick way to learn more about what we do and how we can assist you.

Ready to Transform Your Research?

If you’re seeking a trusted partner for the collection and transport of clinical specimens, MT Group is here to help. Our custom biospecimen collections and comprehensive clinical annotations are designed to meet your specific research needs, providing the quality and precision required to achieve impactful results. Contact us today to discuss your project and discover how we can support your journey toward scientific discovery.

Reach out via our contact page to start the conversation. Looking to join our mission? Explore our current job openings to see how you can contribute to our work. For details on our global network, visit our sites page to learn about the locations powering our specimen collections.


Blood and tissue for early detection, MRD, and Tx guidance assays. High risk controls, longitudinal draws and more.
Current Topic
Biospecimens for Liquid Biopsy
Current Topic
Small Cell Lung Cancer (SCLC) FFPE